StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BHC

Bausch Health Companies Inc.

BHC NYSE Pharmaceutical Preparations EDGAR ↗
$7.00
+0.97 +16.09%

Key statistics

from XBRL data in SEC filings
Market cap
$2.62B
Revenue (TTM)
$10.9B
Net income (TTM)
-$1.10B
EPS (TTM)
$-2.96
P/E ratio
Dividend yield
18.29%
Free cash flow
$1.00B
Cash
$1.82B
Total assets
$24.8B
Gross margin
52-week range
$4.33 – $8.69

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release) Jul 29, 2026 8-K Director or officer change; Regulation FD disclosure Jul 1, 2026 8-K Shareholder vote results May 19, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release) Apr 29, 2026 8-K Director or officer change Mar 2, 2026 10-K Fiscal year ended 2025-12-31 Feb 19, 2026 8-K Results of operations (earnings release) Feb 18, 2026 8-K Regulation FD disclosure Jan 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Other events Jan 2, 2026 8-K Entered a material agreement; Took on a direct financial obligation Dec 29, 2025 8-K Other events Dec 23, 2025 8-K Other events Dec 12, 2025 8-K Other events Dec 9, 2025 8-K Other events Nov 24, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release) Oct 29, 2025 8-K Shareholder vote results Oct 9, 2025 8-K Other events Sep 11, 2025 8-K Terminated a material agreement; Director or officer change; Regulation FD disclosure Aug 15, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release) Jul 30, 2025 8-K Other events Jul 29, 2025 8-K Director or officer change; Regulation FD disclosure Jul 24, 2025 8-K Director or officer change; Regulation FD disclosure Jul 10, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Other events Jun 27, 2025 8-K Other events Jun 18, 2025 8-K Other events Jun 10, 2025 8-K Entered a material agreement May 21, 2025 8-K Director or officer change May 15, 2025 8-K Shareholder vote results May 14, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) Apr 30, 2025 8-K Entered a material agreement; Modified rights of security holders; Regulation FD disclosure Apr 15, 2025 8-K Entered a material agreement; Took on a direct financial obligation Apr 9, 2025 8-K Other events Mar 25, 2025 8-K Other events Mar 19, 2025 10-K Fiscal year ended 2024-12-31 Feb 20, 2025